---
title: "Jim Cramer on Astera Labs: “I Cannot Get Behind It at These Prices”"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/267938206.md"
description: "Jim Cramer expressed skepticism about Astera Labs, Inc. (NASDAQ:ALAB) due to its high valuation, selling at 82 times earnings, despite its robust margins and triple-digit revenue growth. He advised caution at current prices."
datetime: "2025-11-29T18:51:53.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/267938206.md)
  - [en](https://longbridge.com/en/news/267938206.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/267938206.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/267938206.md) | [繁體中文](https://longbridge.com/zh-HK/news/267938206.md)


# Jim Cramer on Astera Labs: “I Cannot Get Behind It at These Prices”

Astera Labs, Inc. (NASDAQ:ALAB) is one of the stocks Jim Cramer recently answered questions about. A caller noted that the stock has been on their watchlist, and mentioned its robust margins and triple-digit revenue growth. In response, Cramer commented: “You know, look, it sells at 82 times earnings. I mean, there’s just… it’s the most \[…\]

### Related Stocks

- [Astera Labs, Inc. (ALAB.US)](https://longbridge.com/en/quote/ALAB.US.md)

## Related News & Research

- [Greenland Capital Management LP Takes $208,000 Position in Astera Labs, Inc. $ALAB](https://longbridge.com/en/news/266745849.md)
- [Swiss National Bank Takes $22.41 Million Position in Astera Labs, Inc. $ALAB](https://longbridge.com/en/news/267540562.md)
- [Iconic Labs Warns on Going Concern as It Hunts £30m Reverse Takeover Target](https://longbridge.com/en/news/281146039.md)
- [Alchemy Labs Inc. Files Preliminary Prospectus for Initial Public Offering of Units](https://longbridge.com/en/news/281195716.md)
- [08:03 ETSpektrum Labs Named Winner of the 2026 SC Award for Best Emerging Technology](https://longbridge.com/en/news/281015575.md)